New Products In Brief
This article was originally published in The Gray Sheet
The latest product approvals and launches.
You may also be interested in...
GenMark Diagnostics prices $42 million secondary offering. Oxford Immunotec raises $28 million for TB test commercialization efforts. Benvenue Medical gets $25 million for spinal devices. More financings.
Recent product approvals and launches
DFine plans to begin a gradual commercial launch late this year of its STAR system, designed to help cancer patients suffering from painful metastases in the spine.